Importance of familial predisposition to heart failure to the risk of anthracycline related cardiotoxicity: a nationwide study

30 August 2020 (08:30 - 08:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Mrs Ann Banke

Odense University Hospital, Odense (Denmark)

5 More presentations in this session

Presentation thumbnail

Chronic obstructive pulmonary disease in heart failure: influence on circulating biomarkers and outcome

Doctor G. Vergaro (Pisa, IT)

Abstract Slides

Presentation thumbnail

36,269 patients with chronic cardiovascular, metabolic and renal conditions: impact on clinical outcomes, medical resource use and health-related costs of deranged serum potassium levels

Doctor S. Jimenez-Marrero (Barcelona, ES)

Abstract Slides

Presentation thumbnail

Temporal trends in cause-specific readmissions and their risk factors in heart failure patients in Sweden

Doctor X. Cui (Shanghai, CN)

Abstract Slides

Presentation thumbnail

Outcomes, resource utilization and predictors of thirty day readmission in patients with heart failure with preserved ejection fraction (HFpEF): Insights from the Nationwide Readmissions Database 2017

Doctor A. Jha (Boston, US)

Abstract Slides

Presentation thumbnail

Estimated population prevalence of cardiac transthyretin amyloidosis in elderly men derived from incidental cardiac uptake from routine bone scans - 'we're going to need a bigger boat'.

Doctor D. Manning (Sheffield, GB)

Abstract Slides

Access the full session

Session thumbnail

Changing Epidemiology of Heart Failure

The Event

ESC Congress 2020

30 August 2020 08:30 CET

You may be interested in

Congress Session

Chronic kidney disease and heart failure

Congress Session

Rare causes of heart failure

Congress Session

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources